GenesyzeCase StudiesRWE for Reimbursement

RWE for Reimbursement

This case study on Parkinson’s Disease shows how real world evidence can guide reimbursement decisions. Scroll down to discover more…

Previous Study
evidence reimbursement | Genesyze

Client Overview

Medical device company (Major).

Evidence Reimbursement | Genesyze

Research Question (Client problem)

How do we secure reimbursement for deep brain stimulation (DBS) for advanced Parkinson’s Disease, following closure of recruitment to an RCT, but with results pending completion of follow up?
Whilst DBS was already recommended in European clinical guidelines (Level B evidence) as an option for the treatment of motor fluctuations in advanced PD, hospitals were unable to offer the procedure without the means to have costs reimbursed.

Medical published literature | Genesyze

Solution (Our Service)

We reviewed published literature to identify data points for calculations, which were then built into a procedure cost calculator and budget impact model. We considered procedure and drug costs, along with the cost of extended stays and readmissions for complications. Budget impact was then calculated from the perspective of a UK payor. Using the combined results, we created an evidence based option appraisal and investment case for national reimbursement.

healthcare cost saving | Genesyze

Benefits (Results)

The model estimated that, over the lifetime of the patient, the DBS pathway would cost, on average, 46% less than the conventional “drugs only” pathway.
Whilst DBS surgery resulted in increased costs during the first year of treatment, due to a reduction in dependence on drugs for symptom control and their associated disabling side effects, a 23% reduction in total treatment costs was projected for subsequent years.
Taking into account the backlog of patients eligible for treatment, the model predicted that payors would break even by year 6, after which significant savings could be made across the healthcare system.

Medical software | Genesyze

Technology, Programming, Software and Process

Excel

Medical reimbursement | Genesyze

Insights

As a consequence, a tariff and national reimbursement pathway for DBS was established. Real world evidence can guide reimbursement decisions, improving patient access to technology enabled and life enhancing treatments.

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read

This website uses cookies to give you the best experience. If you continue to use this site, we’ll assume that you’re happy to receive all cookies. View our Cookie Policy here.